Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hadas Gantz Sorotsky
Observed names:
H. Sorotsky,
Hadas Sorotsky,
Hadas Yocheved Gantz Sorotsky,
Sorotsky H
Institution:
Sheba Medical Center
Observed institutions:
University Health Network,
Tel Aviv University,
Hebrew University of Jerusalem,
Sheba Medical Center,
Hadassah Medical Center,
Princess Margaret Cancer Centre
show all 6
ORCID:
0000-0003-3310-970X
Observed ORCID:
0000-0003-3310-970X
OpenAlex ID:
A5009921149
RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients
2016
·
Michal Sarfaty
, Assaf Moore
, et al.
·
Clinical Lung Cancer
·
37
Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program
2022
·
Oliver Illini
, Hannah Fabikan
, et al.
·
Therapeutic Advances in Medical Oncology
·
30
PDF
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events
2021
·
Daniel V. Araujo
, Thiago Pimentel Muniz
, et al.
·
Current Oncology
·
27
PDF
Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center
2020
·
Min Joon Lee
, Katrina Hueniken
, et al.
·
Cancer Management and Research
·
18
PDF
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
2022
·
Shira Sagie
, Michal Sarfaty
, et al.
·
Cancers
·
14
PDF
Characteristics of Immune Checkpoint Inhibitors Trials Associated With Inclusion of Patients With HIV
2019
·
Hadas Sorotsky
, David Hogg
, et al.
·
JAMA Network Open
·
11
PDF
Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing
2022
·
Or Sehayek
, Waleed Kian
, et al.
·
Frontiers in Oncology
·
10
PDF
Real-World Data on Osimertinib-Associated Cardiac Toxicity
2025
·
Abed Agbarya
, Ari Raphael
, et al.
·
Journal of Clinical Medicine
·
9
Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma
2022
·
Shira Sagie
, Moran Gadot
, et al.
·
Cancers
·
6
PDF
Lurbinectedin for extensive stage − small cell lung cancer (ES-SCLC): real world response patterns and survival outcomes
2025
·
Belal Krayim
, Walid Shalata
, et al.
·
Lung Cancer
·
5
EGFR Mutation Testing Practice in Advanced Non-Small Cell Lung Cancer
2014
·
Jair Bar
, Arnold Cyjon
, et al.
·
Lung
·
5
Pneumonitis after chemoradiation followed by durvalumab for locally advanced lung cancer: predictors and effect on survival
2025
·
Sarit Appel
, Lee Wilk
, et al.
·
British Journal of Radiology
·
4
Real world characteristics of stages II-III NSCLC patients (pts) who initiate neoadjuvant chemo-immunotherapy (NACT-I) and do not undergo surgical resection.
2025
·
Jair Bar
, Giuseppe Domenico Maiocco
, et al.
·
Journal of Clinical Oncology
·
4
Uncommon EGFR mutations on osimertinib, real-life data (UNICORN study): Updated results, brain efficacy, and resistance mechanisms.
2022
·
Jair Bar
, Nir Peled
, et al.
·
Journal of Clinical Oncology
·
3
Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center
2020
·
Lee MJ
, Hueniken K
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
3
AndroMETa-Lung-713: A phase 2/3 study of telisotuzumab adizutecan (ABBV-400, Temab-A) vs standard of care (SOC) in patients with epidermal growth factor receptor ( EGFR )–mutated non–small cell lung cancer (NSCLC).
2026
·
Adam Rock
, Yi-Long Wu
, et al.
·
Journal of Clinical Oncology
·
2
Quantifying EpCAM heterogeneity of circulating-tumor-cells (CTCs) from small cell lung cancer (SCLC) patients.
2019
·
Hadas Sorotsky
, Mansi Aparanthi
, et al.
·
Journal of Clinical Oncology
·
2
Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor‒Like Melanoma
2021
·
Thiago P. Muniz
, Hadas Sorotsky
, et al.
·
Journal of Investigative Dermatology
·
1
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis
2019
·
Min Joon Lee
, Nathan Kuehne
, et al.
·
Molecular Carcinogenesis
·
1
P3.03-29 The Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer
2018
·
H. Sorotsky
, M. Cabanero
, et al.
·
Journal of Thoracic Oncology
·
1
The effect of prior smoking history on the molecular profile of EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC).
2018
·
Hadas Sorotsky
, Mor Moskovitz
, et al.
·
Journal of Clinical Oncology
·
1
Concomitant radiotherapy, tremelimumab, and durvalumab for advanced NSCLC patients progressing on first-line immunotherapy: A phase 2 study (CORAL-Lung).
2026
·
Jair Bar
, Hadas Gantz Sorotsky
, et al.
·
Journal of Clinical Oncology
Lurbinectedin for small cell lung cancer (SCLC): Response patterns and survival outcomes by line of therapy.
2025
·
Belal C. Krayim
, Jair Bar
, et al.
·
Journal of Clinical Oncology
Efficacy and hepatotoxicity of Infliximab in resolving steroid-refractory immune-related adverse events (irAEs) in a real-world setting.
2020
·
Thiago Pimentel Muniz
, Daniel Vilarim Araujo
, et al.
·
Journal of Clinical Oncology
Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)-like melanoma.
2020
·
Thiago Pimentel Muniz
, Hadas Sorotsky
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
32
Citation count:
194
H-index:
8
I10-index:
7
Year
Topic
Type
